搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant African swine fever virus Uncharacterized protein C129R (Ken-074) CSB-YP316494AEB
CSB-EP316494AEB
CSB-BP316494AEB
CSB-MP316494AEB
CSB-EP316494AEB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein G1340L (War-099), partial CSB-YP316495AEI
CSB-EP316495AEI
CSB-BP316495AEI
CSB-MP316495AEI
CSB-EP316495AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein E146L (Ken-141), partial CSB-YP316496AEB
CSB-EP316496AEB
CSB-BP316496AEB
CSB-MP316496AEB
CSB-EP316496AEB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Protein A151R (War-047) CSB-YP316497AEI
CSB-EP316497AEI
CSB-BP316497AEI
CSB-MP316497AEI
CSB-EP316497AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein F165R (Ken-058), partial CSB-YP316498AEB1
CSB-EP316498AEB1
CSB-BP316498AEB1
CSB-MP316498AEB1
CSB-EP316498AEB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Transmembrane protein B169L (War-086), partial CSB-YP316499AEI1
CSB-EP316499AEI1
CSB-BP316499AEI1
CSB-MP316499AEI1
CSB-EP316499AEI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Membrane protein I177L (Ken-156), partial CSB-YP316500AEB
CSB-EP316500AEB
CSB-BP316500AEB
CSB-MP316500AEB
CSB-EP316500AEB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein S183L (Ken-122) CSB-YP316501AEB
CSB-EP316501AEB
CSB-BP316501AEB
CSB-MP316501AEB
CSB-EP316501AEB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Late protein I196L (Ken-157) CSB-YP316502AEB
CSB-EP316502AEB
CSB-BP316502AEB
CSB-MP316502AEB
CSB-EP316502AEB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein K205R (Mal-056) CSB-YP316503AYE
CSB-EP316503AYE
CSB-BP316503AYE
CSB-MP316503AYE
CSB-EP316503AYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Late protein I226R (Pret-150) CSB-YP316504AYG
CSB-EP316504AYG
CSB-BP316504AYG
CSB-MP316504AYG
CSB-EP316504AYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein H240R (Pret-132) CSB-YP316505AYG
CSB-EP316505AYG
CSB-BP316505AYG
CSB-MP316505AYG
CSB-EP316505AYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein I267L (Ken-148) CSB-YP316506AEB
CSB-EP316506AEB
CSB-BP316506AEB
CSB-MP316506AEB
CSB-EP316506AEB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein CP312R (Pret-108) CSB-YP316507AYG
CSB-EP316507AYG
CSB-BP316507AYG
CSB-MP316507AYG
CSB-EP316507AYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein C315R (War-078) CSB-YP316508AEI
CSB-EP316508AEI
CSB-BP316508AEI
CSB-MP316508AEI
CSB-EP316508AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Transmembrane protein I329L (War-152), partial CSB-YP316509AEI
CSB-EP316509AEI
CSB-BP316509AEI
CSB-MP316509AEI
CSB-EP316509AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein B354L (War-088) CSB-YP316510AEI
CSB-EP316510AEI
CSB-BP316510AEI
CSB-MP316510AEI
CSB-EP316510AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein B407L (War-094) CSB-YP316511AEI
CSB-EP316511AEI
CSB-BP316511AEI
CSB-MP316511AEI
CSB-EP316511AEI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Uncharacterized protein E423R (Ken-139) CSB-YP316512AEB
CSB-EP316512AEB
CSB-BP316512AEB
CSB-MP316512AEB
CSB-EP316512AEB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Protein B602L (Pret-091), partial CSB-YP316513AYG
CSB-EP316513AYG
CSB-BP316513AYG
CSB-MP316513AYG
CSB-EP316513AYG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>